EATG » Access

Access

Groups call for end to Gilead’s unwarranted hepatitis C drug monopoly in Europe

Gilead’s price gouging for sofosbuvir blocks millions of people from getting treatment NEW YORK/MUNICH/PARIS, SEPTEMBER 11, 2018—This week in Munich, the European Patent Office (EPO) will hear a legal challenge…

New confidential text shows draft deal on UN TB Declaration

A newly agreed draft text of the United Nations political declaration on tuberculosis was released to governments today, affirming the use of flexibilities in international trade rules on intellectual property,…

UN TB negotiations: What is at stake?

With negotiations over the final language of a United Nations high level declaration on ending tuberculosis still ongoing, the stakes are high as different TB stakeholders await the outcome. The…

China patent challenge compels Gilead to withdraw key patent claims on sofosbuvir base compound

China patent challenge compels Gilead to withdraw key patent claims on sofosbuvir base compound, opening life-saving hepatitis C treatment access for millions I-MAK’s successful patent challenge against Gilead cracks open…

Open letter: UN General Assembly High Level Meeting on the fight against Tuberculosis

Few weeks before the UN General Assembly High Level Meeting on the fight against Tuberculosis, the EATG issues an open letter: 'As negotiations on the final declaration are now being…

The EATG welcomes the European Court of Justice decision to invalidate the patent extension of Truvada

Amsterdam, 26 July 2018   The European AIDS Treatment Group welcomes the landmark decision of the European Court of Justice confirming the invalidity of the patent extension (Supplementary Protection Certificate)…

AIDS 2018: Terrence Higgins Trust launches Access Fund to support people who can’t afford HIV prevention drug PrEP

The fund will launch in the autumn and is intended to support up to 1,000 people in England and Northern Ireland. The fund, which launches this autumn, intends to support…

AIDS 2018: Hologic’s Global Access Initiative Increases Availability of Diagnostic Testing in Resource-Limited Countries

Program focuses on infectious disease assays - including HIV - for countries where critical testing is needed most MARLBOROUGH, Mass., July 25, 2018 -- Hologic, Inc. (NASDAQ: HOLX) announced today the…

AIDS 2018: Studies raise concerns about policies seeking to “end demand” for sex work

Analysis of laws in Canada and France 26 July 2018 (Amsterdam, the Netherlands) – Research suggests that “end demand” laws are reducing demand for HIV services, according to panellists sharing the…

AIDS 2018: Game over for Gilead’s monopoly on Truvada

AIDES and Coalition PLUS welcome the ruling of the Court of  Justice of the European Union Read the press release here.